Illegal drug market responses to state recreational cannabis laws

Abstract

Background and AimsIn the United States, 15 states and the District of Columbia have implemented recreational cannabis laws (RCLs) legalizing recreational cannabis use. We aimed to estimate the association between RCLs and street prices, potency, quality and law enforcement seizures of illegal cannabis, methamphetamine, cocaine, heroin, oxycodone, hydrocodone, morphine, amphetamine and alprazolam. Design We pooled crowdsourced data from 2010-19 Price of Weed and 2010-19 StreetRx, and administrative data from the 2006-19 System to Retrieve Information from Drug Evidence (STRIDE) and the 2007-19 National Forensic Laboratory Information System (NFLIS). We employed a difference-in-differences design that exploited the staggered implementation of RCLs to compare changes in outcomes between RCL and non-RCL states. Setting and cases Eleven RCL and 40 non-RCL US states. Measures The primary outcome was the natural log of prices per gram, overall and by self-reported quality. The primary policy was an indicator of RCL implementation, defined using effective dates. Findings The street price of cannabis decreased by 9.2% [β = À0.092; 95% confidence interval (CI) = À0.15-, -0.03] in RCL states after RCL implementation, with largest declines among low-quality purchases (β = À0.195; 95% CI = -0.282, -0.108). Price declines were accompanied by a 93% (β = À0.93; 95% CI = -1.51, -0.36) reduction in law enforcement seizures of cannabis in RCL states. Among illegal opioids, including heroin, oxycodone and hydrocodone, street prices increased and law enforcement seizures decreased in RCL states. Conclusions Recreational cannabis laws in US states appear to be associated with illegal drug market responses in those states, including reductions in the street price of cannabis. Changes in the street prices of illegal opioids analyzed may suggest that in states with recreational cannabis laws the markets for other illegal drugs are not independent of legal cannabis market regulation.

Prenatal substance use policies and newborn health

“…In robustness checks, we test the sensitivity of findings to a host of secondary control variables that account for other drug policies affecting the supply or demand for substances. These include prescription drug monitoring program operations and mandates, pain clinic laws, medical and recreational cannabis legalization, law enforcement seizures of fentanyl, heroin, and oxycodone, beer taxes, cigarette taxes, the rate of SUD treatment providers, the Affordable Care Act Medicaid expansions, and reporting PSUPs and targeted SUD treatment funding PSUPs (Meinhofer et al., 2018, 2021a, 2021b).…”

Germany's cannabis act: a catalyst for European drug policy reform?

“…While acknowledging the uncertainties in observational study designs, we propose that the main causal mechanism leading to increasing use and health problems lies in legal market dynamics. Specifically, we identify three core pathways: (1) the increasing availability of cannabis, e.g., through a high-density network of retailers, in particular in jurisdictions with private distribution models, 18 or through online delivery options 19 ; (2) the falling retail prices of cannabis in both legal 20 and illegal markets, 21 making a standard dose much more affordable; 3) the supply of new, innovative products that are attractive for people who did not use cannabis before (e.g., edibles, tinctures) or that allow for a much higher intake of THC than through traditional means of consumption (concentrates, vapes; see 22 :).…”

Interpol Review of Drug Analysis 2019-2022

“…2021 marijuana cultivation security requirements, laws and regulations [ 431 ]; study to estimate the association between recreational cannabis laws and street prices, potency, quality and law enforcement seizures of illegal cannabis, methamphetamine, cocaine, heroin, oxycodone, hydrocodone, morphine, amphetamine and alprazolam [ 432 ]; review that provides background on the history and botany of Cannabis as well as a summary of Cannabis tissue culture [ 433 ]; study to measure the aromatic properties of cannabis flowers and concentrated extracts using comprehensive two-dimensional GC-TOF, FID, and sulfur chemiluminescence [ 434 ]; 2022.…”